accountThe results of this study should change the way we treat patients with Alzheimer's disease. Cholinesterase inhibitors are approved for use in mild to moderate dementia, while memantine has been approved for advanced dementia. But it looks like there is an advantage in prescribing both drugs as initial treatment.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The Combination of Aricept and Namenda Helps Slow the Rate of Decline in Alzheimer's Patients
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
